J
Jill Gilbert
Researcher at Vanderbilt University
Publications - 127
Citations - 7787
Jill Gilbert is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Head and neck cancer & Cancer. The author has an hindex of 41, co-authored 124 publications receiving 6552 citations. Previous affiliations of Jill Gilbert include Vanderbilt University Medical Center & Case Western Reserve University.
Papers
More filters
Journal ArticleDOI
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.
Paulo C. Rodriguez,Claudia Hernandez,David G. Quiceno,Steven M. Dubinett,Jovanny Zabaleta,Juan B. Ochoa,Jill Gilbert,Augusto C. Ochoa +7 more
TL;DR: A new pathway of prostaglandin-induced immune dysfunction is demonstrated and a novel mechanism that can help explain the cancer prevention effects of COX-2 inhibitors is provided, which represents a clinical approach to enhance the therapeutic potential of cancer immunotherapies.
Journal ArticleDOI
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.
Joshua Bauml,Tanguy Y. Seiwert,David G. Pfister,Francis P. Worden,Stephen V. Liu,Jill Gilbert,Nabil F. Saba,Jared Weiss,Lori J. Wirth,Ammar Sukari,Hyunseok Kang,Michael K. Gibson,Erminia Massarelli,Steven M. Powell,Amy Meister,Xinxin Shu,Jonathan D. Cheng,Robert I. Haddad +17 more
TL;DR: Pembrolizumab exhibited clinically meaningful antitumor activity and an acceptable safety profile in recurrent/metastatic head and neck squamous cell carcinoma previously treated with platinum and cetuximab and in subgroups on the basis of programmed death ligand 1 (PD-L1) expression and human papillomavirus (HPV) status.
Journal ArticleDOI
Head and Neck Cancers
David G. Pfister,K. Kian Ang,David M. Brizel,Barbara Burtness,Anthony J. Cmelak,A. Dimitrios Colevas,Frank Dunphy,David W. Eisele,Jill Gilbert,Maura L. Gillison,Robert I. Haddad,Bruce H. Haughey,Wesley L. Hicks,Ying J. Hitchcock,Merrill S. Kies,William M. Lydiatt,Ellie Maghami,Renato G. Martins,Thomas V. McCaffrey,Bharat B. Mittal,Harlan A. Pinto,John A. Ridge,Sandeep Samant,Giuseppe Sanguineti,David E. Schuller,Jatin P. Shah,Sharon A. Spencer,Andy Trotti,Randal S. Weber,Gregory T. Wolf,Frank Worden +30 more
TL;DR: The role of eIF4E and some other translation factors as they relate to the biology and treatment of HNSCC are discussed.
Journal ArticleDOI
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
A. Dimitrios Colevas,Sue S. Yom,David G. Pfister,Sharon A. Spencer,David J. Adelstein,Douglas Adkins,David M. Brizel,Barbara Burtness,Paul M. Busse,Jimmy J. Caudell,Anthony J. Cmelak,David W. Eisele,Moon Fenton,Robert L. Foote,Jill Gilbert,Maura L. Gillison,Robert I. Haddad,Wesley L. Hicks,Ying J. Hitchcock,Antonio Jimeno,Debra S. Leizman,Ellie Maghami,Loren K. Mell,Bharat B. Mittal,Harlan A. Pinto,John A. Ridge,James W. Rocco,Cristina P. Rodriguez,Jatin P. Shah,Randal S. Weber,Matthew E. Witek,Frank Worden,Weining Zhen,Jennifer L. Burns,Susan Darlow +34 more
TL;DR: These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding evaluation and treatment of nasopharyngeal carcinoma.
Journal ArticleDOI
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.
Shanthi Marur,Shuli Li,Anthony J. Cmelak,Maura L. Gillison,Weiqiang Zhao,Robert L. Ferris,William H. Westra,Jill Gilbert,Julie E. Bauman,Lynne I. Wagner,David Trevarthen,Jahagirdar Balkrishna,Barbara A. Murphy,Nishant Agrawal,A. Dimitrios Colevas,Christine H. Chung,Barbara Burtness +16 more
TL;DR: For IC responders, reduced-dose IMRT with concurrent cetuximab is worthy of further study in favorable-risk patients with HPV-associated OPSCC, and radiation dose reduction resulted in significantly improved swallowing and nutritional status.